Answers are grounded in this paper and cite their sources.
Langerhans cell histiocytosis (LCH) has presented problems in diagnosis and in treatment. The definitive diagnosis is a pathologic one. To advance thorough and uniform assessment of these patients, the elements of a complete clinical and laboratory evaluation are presented by the Histiocyte Society. Adoption of a uniform clinical/laboratory approach to these children, coupled with agreed-upon steps to the pathologic identification of LCH, should result in a better understanding and ultimately better and more rational therapies for the disease.
No takes yet. Share an insight, caveat, or question.
Broadbent et al. (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: